Skip to main content

$0.265 0.005 (1.92%)

High

$0.27

Low

$0.26

Trades

10

Turnover

$30,696

Volume

117,402
30 June 2023 at 3:52pm
Register to track EYE and receive email alerts.
Subject
EYE Ann: Investment Presentation

EYE Ann: Change of Director's Interest Notice

EYE Ann: Change of Director's Interest Notice

EYE Ann: Change of Director's Interest Notice

EYE Ann: Change of Director's Interest Notice

EYE Ann: Change in substantial holding

EYE Ann: Application for quotation of securities - EYE

EYE Ann: Cleansing Notice

EYE Ann: iTrack Advance First Surgeries and Sales in USA

EYE Ann: Results of General Meeting

EYE Ann: FDA Clears iTrack Advance for US Launch

EYE Ann: Notice Of General Meeting

EYE Ann: Cleansing notice

EYE Ann: Application for quotation of securities - EYE

EYE Ann: Proposed issue of securities - EYE

EYE Ann: Reinstatement to Quotation

EYE Ann: Investor Presentation

EYE Ann: Nova Eye Completes Placement

EYE Ann: Suspension from Official Quotation

EYE Ann: Half Year Accounts

EYE Ann: Trading Halt

EYE Ann: Glaucoma Surgical Devices Sales Update

EYE Ann: Notification of cessation of securities - EYE

EYE Ann: Additional Clinical Application for 2RT

EYE Ann: Status of MArket Clearance for iTrack Advance in the USA

EYE Ann: Application for quotation of securities - EYE

EYE Ann: AGM Voting Results

EYE Ann: AGM presentation 2022

EYE Ann: Clarification Glaucoma Surgical Devices Sales Update

EYE Ann: Glaucoma Surgical Devices Sales Update

EYE Ann: AlphRet Completes Initial Recruitment of Investigator Sites

EYE Ann: Notice of Annual General Meeting 2022

EYE Ann: Notification regarding unquoted securities - EYE

EYE Ann: Application for quotation of securities - EYE

EYE Ann: Notification regarding unquoted securities - EYE

EYE Ann: 2RT Presentation Professor Robyn H Guymer

EYE Ann: Appendix 3Y T Spurling

EYE Ann: AGM Date and Directors Nominations

EYE Ann: 2RT Webinar Professor Robyn H Guymer MMBBS, PHD

EYE Ann: Notification of cessation of securities - EYE

EYE Ann: Notification of cessation of securities - EYE

EYE Ann: Appendix 4G and Corporate Governance Statement

EYE Ann: Investor Presentation FY22

EYE Ann: Results Announcement FY22

EYE Ann: Appendix 4E and Annual Report FY22

EYE Ann: Expiry of Voluntary Escrow Conditions

EYE Ann: Glaucoma Sales update

EYE Ann: iTrack Advance Commercial Roll-Out Commenced

EYE Ann: Notification regarding unquoted securities - EYE

EYE Ann: Application for quotation of securities - EYE

Register to track EYE and receive email alerts.

Similar Companies

AT1
COH
CSX
CYC
EMV
IBX
IPD
MX1
RSH
SOM